Denosumab and alendronate provide similar fracture outcomes: study
Better bone mineral density may not necessarily translate into fewer fractures, authors say
6th May 2019
Rates of osteoporotic fracture are similar three years after starting either denosumab or alendronate, according to a real-world Danish population-based cohort study.